317 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
Rank Status Study
21 Recruiting Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
22 Unknown  Pioglitazone in Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Pioglitazone
23 Unknown  Q-Trial in Patients With Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Dietary Supplement: Quercetin
24 Unknown  Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection;   Hepatitis C
Intervention: Behavioral: Contigent voucher incentive (CVI)
25 Unknown  Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha 2a and plus ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: pegylated interferon alpha 2a and ribavirin
26 Recruiting DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)
Condition: Early Chronic Hepatitis C
Intervention: Drug: TPV/PEG-IFN/RBV
27 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL with Ribavirin;   Drug: Chlorcyclizine HCL
28 Unknown  Directly Observed Hepatitis C Treatment in Methadone Clinics
Conditions: Hepatitis C;   Medication Adherence
Interventions: Other: enhanced DOT (both pegylated interferon alfa-2a and ribavirin);   Other: standard DOT (PEG-DOT control arm)
29 Recruiting The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Condition: Hepatitis C
Intervention: Biological: Peginterferon lambda
30 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
31 Unknown  A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin
32 Unknown  Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
33 Recruiting Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Reiferon retard
34 Recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857
35 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
36 Unknown  Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Conditions: Chronic Hepatitis c;   Insulin Resistance
Interventions: Drug: metformin;   Drug: pegylated-IFN;   Drug: ribavirin
37 Recruiting BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: BIP 48 (Peginterferon alfa 2b 48kDA);   Drug: Peginterferon alfa 2a 40kDA
38 Recruiting The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Condition: Hepatitis C Recurrence After Liver Transplant
Interventions: Drug: EVL arm;   Drug: MMF arm
39 Unknown  Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
Condition: Chronic Hepatitis C
Intervention:
40 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years